|
Volumn 24, Issue 4 SUPPL.12, 1997, Pages
|
Single-agent paclitaxel in advanced non-small cell lung cancer: Single- center phase II study using a 3-hour administration schedule
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CHLORPHENIRAMINE;
CIMETIDINE;
DEXAMETHASONE;
PACLITAXEL;
ANTINEOPLASTIC AGENT;
ADULT;
ADVANCED CANCER;
AGED;
ALOPECIA;
ANOREXIA;
ARTHRALGIA;
BONE MARROW SUPPRESSION;
CANCER CHEMOTHERAPY;
CANCER STAGING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG SAFETY;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
MALE;
MUCOSA INFLAMMATION;
MYALGIA;
ORAL DRUG ADMINISTRATION;
PERIPHERAL NEUROPATHY;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
ARTICLE;
DRUG ADMINISTRATION;
LUNG TUMOR;
MIDDLE AGED;
PATHOLOGY;
QUALITY OF LIFE;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CARCINOMA, NON-SMALL-CELL LUNG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
PACLITAXEL;
QUALITY OF LIFE;
|
EID: 0030846166
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (15)
|
References (10)
|